ConductScience.org, home

Paper6503501

[Effect of local moderate hyperthermia in combination with chemotherapy by N-nitroso-1,3-bis-(2-chloroethyl)urea (BCNU) on the descending colon of the rat with transplanted Yoshida sarcoma. 2. Monochemotherapy in combination with subsequent hyperthermia at various time intervals].

Lorenz M and 3 others. Langenbecks Arch Chir, 1984. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. [Effect of local moderate hyperthermia in combination with chemotherapy by N-nitroso-1,3-bis-(2-chloroethyl)urea (BCNU) on the descending colon of the rat with transplanted Yoshida sarcoma. 2. Monochemotherapy in combination with subsequent hyperthermia at various time intervals]. Papers, record 6503501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6503501

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Effect of local moderate hyperthermia in combination with chemotherapy by N-nitroso-1,3-bis-(2-chloroethyl)urea (BCNU) on the descending colon of the rat with transplanted Yoshida sarcoma. 2. Monochemotherapy in combination with subsequent hyperthermia at various time intervals].
PubMed
Journal
Langenbecks Arch Chir
PubMed
Year
1984
PubMed
Publication types
English Abstract, Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.13
iCite
Revised in PubMed
2019-08-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lorenz MM
2Biwer EE
3Habs MM
4Schmähl DD

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarmustineMajor topic
Colonic NeoplasmsMajor topic
Hyperthermia, InducedMajor topic
Sarcoma, YoshidaMajor topic
Animals
Combined Modality Therapy
Male
Neoplasm Transplantation
Prognosis
Rats
Rats, Inbred Strains
Time Factors

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14701703Hyperthermia (42 degrees C) as an adjuvant to radiotherapy and chemotherapy in the treatment of the allogeneic VX2 carcinoma in the rabbit.Br J Cancer1973https://conductscience.org/library/papers/4701703PubMed
24299395[Extreme hyperthermia studies on 4 different tumors in rats].Z Krebsforsch1967https://conductscience.org/library/papers/4299395PubMed
36883282Effect of timing and sequence of hyperthermia and cyclophosphamide on a neurogenic rat tumor (BT4A) in vivo.Cancer1983https://conductscience.org/library/papers/6883282PubMed
47198938Whole-body hyperthermia and chemotherapy for treatment of patients with advanced, refractory malignancies.Cancer Treat Rep1982https://conductscience.org/library/papers/7198938PubMed
5775137Tumor eradication by radiofrequency therapy. Responses in 21 patients.JAMA1976https://conductscience.org/library/papers/775137PubMed
66876999
[Effect of moderate local hyperthermia in combination with chemotherapy with cyclophosphamide or N-nitroso- 1,3-bis(2-chloroethyl)urea(BCNU) on Yoshida sarcoma implanted in the descending colon of rats. 1. Repeated hyperthermia within 8 days and combination of chemotherapy followed by hyperthermia 24 h later].
Langenbecks Arch Chir1983https://conductscience.org/library/papers/6876999PubMed
787263Potential for therapy of drugs and hyperthermia.Cancer Res1979https://conductscience.org/library/papers/87263PubMed
8975042Selective lethal effect of supranormal temperatures on human neoplastic cells.Cancer Res1976https://conductscience.org/library/papers/975042PubMed
97308265Synergism between hyperthermia and cyclophosphamide in vivo: the effect of dose fractionation.Eur J Cancer (1965)1981https://conductscience.org/library/papers/7308265PubMed
10831755Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.Br J Cancer1977https://conductscience.org/library/papers/831755PubMed
117444064The effect of hyperthermia on vascular function, pH, and cell survival.Radiology1980https://conductscience.org/library/papers/7444064PubMed
126832025[Extracorporeally induced whole-body hyperthermia in conventionally incurable malignant tumor patients].Dtsch Med Wochenschr1983https://conductscience.org/library/papers/6832025PubMed
134292219Selective heat sensitivity of cancer cells. Biochemical and clinical studies.Cancer1967https://conductscience.org/library/papers/4292219PubMed
146659526Intraperitoneal approach to regional hyperthermia--possible anticancer applications.World J Surg1983https://conductscience.org/library/papers/6659526PubMed
157362770Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.Br J Cancer1980https://conductscience.org/library/papers/7362770PubMed
166766084Clinical delivery system for intraperitoneal hyperthermic chemotherapy.Cancer Res1980https://conductscience.org/library/papers/6766084PubMed
177188883In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C.Cancer Res1980https://conductscience.org/library/papers/7188883PubMed
1887264Interactions of hyperthermia and chemotherapy in animals.Cancer Res1979https://conductscience.org/library/papers/87264PubMed
19468900
Antitumor activity of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea (MeCCNU) on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
J Cancer Res Clin Oncol1979https://conductscience.org/library/papers/468900PubMed
204363651In vitro-in vivo studies on the susceptibility of the solid Yoshida sarcoma to drugs and hyperthermia (42 degrees).Cancer Res1974https://conductscience.org/library/papers/4363651PubMed

See all 29 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
6439968
[Effect of local moderate hyperthermia in combination with N-nitroso-1,3-bis-(2-chloroethyl)urea (BCNU) and 5-fluoro-(tetrahydro-2-furyl)uracil (ftorafur) on induced autochthonous colonic cancers in the rat. 3: Polychemotherapy in combination with hyperthermia].
Langenbecks Arch Chir1984https://conductscience.org/library/papers/6439968

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6503501

GET https://conductscience.org/api/papers/v1/6503501/references?page=2